4014
SA:COM:SMEH
دار المعدات الطبية والعلمية
- Stock
Last Close
40.10
01/05 12:18
Market Cap
1.60B
Beta: -
Volume Today
68.49K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 48.62M - | 97.46M 100.45% | ||||||
average payables | 30.07M - | 64.32M 113.87% | ||||||
average receivables | 362.90M - | 675.83M 86.23% | ||||||
book value per share | 12.70 - | 15.03 18.34% | 17.79 18.35% | 21.40 20.26% | 23.67 10.62% | 23.52 0.65% | ||
capex per share | ||||||||
capex to depreciation | ||||||||
capex to operating cash flow | ||||||||
capex to revenue | ||||||||
cash per share | 28.52 - | 27.01 5.28% | 23.74 12.11% | 2.27 90.45% | 2.73 20.38% | |||
days of inventory on hand | 64.95 - | 63.78 1.79% | ||||||
days payables outstanding | 40.17 - | 44.72 11.32% | ||||||
days sales outstanding | 378.75 - | 320.02 15.51% | ||||||
debt to assets | 0.00 - | 0.01 59.59% | 0.26 3,748.64% | 0.22 15.19% | ||||
debt to equity | 0.01 - | 0.01 36.95% | 0.56 3,881.58% | 0.44 21.91% | ||||
dividend yield | ||||||||
earnings yield | 0.03 - | 0.05 37.71% | 0.03 27.30% | 0.05 51.06% | 0.05 3.70% | 0.02 61.26% | ||
enterprise value | 1.60B - | 1.15B 28.52% | 1.12B 1.82% | 1.14B 1.80% | 1.66B 44.74% | 992.00M 40.13% | ||
enterprise value over ebitda | 22.38 - | 11.93 46.69% | 12.23 2.54% | 11.88 2.87% | 16.77 41.11% | 20.36 21.42% | ||
ev to operating cash flow | 20.57 - | -10.55 151.29% | 6.91 165.46% | 9.76 41.30% | -19.56 300.42% | 8.00 140.90% | ||
ev to sales | 2.88 - | 1.96 31.95% | 1.88 3.97% | 1.75 6.83% | 2.37 35.00% | 1.39 41.34% | ||
free cash flow per share | 3.90 - | -5.43 239.35% | 8.14 249.99% | 5.87 27.95% | -4.24 172.22% | 6.20 246.38% | ||
free cash flow yield | 0.05 - | -0.08 239.35% | 0.11 249.99% | 0.08 27.95% | -0.06 172.22% | 0.15 350.23% | ||
graham net net | -32.86 - | -13.75 58.17% | -16.08 16.97% | -20.73 28.92% | 4.71 122.71% | 5.52 17.25% | ||
graham number | 26.58 - | 33.93 27.66% | 31.48 7.24% | 42.42 34.78% | 45.44 7.10% | 21.56 52.55% | ||
income quality | 1.58 - | -1.59 201.19% | 7.06 - | |||||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.00 Infinity% | 0 100% | |
interest coverage | 5.08 - | 5.01 1.25% | 4.34 13.45% | 6.52 50.16% | 7.07 8.46% | 2.41 65.84% | ||
interest debt per share | 0.70 - | 0.85 20.28% | 1.24 46.52% | 1.04 16.18% | 14.01 1,245.47% | 11.38 18.80% | ||
inventory turnover | 5.62 - | 5.72 1.83% | ||||||
invested capital | 0.01 - | 0.01 36.95% | 0.56 3,881.58% | 0.44 21.91% | ||||
market cap | 1.44B - | 1.44B 0% | 1.44B 0% | 1.44B 0% | 1.44B 0% | 840M 41.50% | ||
net current asset value | -28.43M - | -26.35M 7.34% | -68.88M 161.44% | -86.22M 25.17% | 397.53M 561.08% | 375.77M 5.47% | ||
net debt to ebitda | 2.32 - | -3.03 230.46% | -3.39 11.90% | -3.02 10.80% | 2.24 173.94% | 3.12 39.53% | ||
net income per share | 2.47 - | 3.40 37.71% | 2.47 27.30% | 3.74 51.06% | 3.88 3.70% | 0.88 77.34% | ||
operating cash flow per share | 3.90 - | -5.43 239.35% | 8.14 249.99% | 5.87 27.95% | -4.24 172.22% | 6.20 246.38% | ||
payables turnover | 9.09 - | 8.16 10.17% | ||||||
receivables turnover | 0.96 - | 1.14 18.35% | ||||||
research and ddevelopement to revenue | ||||||||
return on tangible assets | 0.08 - | 0.08 7.08% | 0.06 28.70% | 0.08 46.38% | 0.08 9.39% | 0.02 75.13% | ||
revenue per share | 27.80 - | 29.20 5.04% | 29.85 2.24% | 32.62 9.27% | 34.97 7.22% | 35.69 2.05% | ||
roe | 0.19 - | 0.23 16.37% | 0.14 38.57% | 0.17 25.61% | 0.16 6.26% | 0.04 77.19% | ||
roic | 0.24 - | 0.24 0.55% | 0.18 27.79% | 0.16 8.71% | 0.12 25.80% | 0.04 65.59% | ||
sales general and administrative to revenue | -0.03 - | -0.02 35.43% | -0.02 0.25% | -0.02 3.04% | 0.08 581.49% | 0.09 21.32% | ||
shareholders equity per share | 12.70 - | 15.03 18.34% | 17.79 18.35% | 21.40 20.26% | 23.67 10.62% | 23.52 0.65% | ||
stock based compensation to revenue | ||||||||
tangible asset value | 473.68M - | 464.93M 1.85% | ||||||
tangible book value per share | 23.68 - | 23.43 1.07% | ||||||
working capital | 279.49M - | 344.34M 23.20% | 356.17M 3.44% | 400.58M 12.47% | 467.33M 16.66% | 459.66M 1.64% |
All numbers in (except ratios and percentages)